INS and type 2 diabetes mellitus: This is the first analysis of prospective and comprehensive patient-reported outcomes from a randomized, clinical trial of severely insulin-resistant patients with type 2 diabetes who were switched from high-dose U-100 insulin regimens to U-500R as insulin monotherapy.